Study compares efficacy of BNT162b2 and CoronaVac as the booster dose for COVID-19 vaccination

By | November 9, 2021
A recent study reports the immunogenicity and safety of BNT162b2 and CoronaVac as the third dose in CoronaVac-immunized adults.